A research agenda for malaria eradication: drugs.


malERA Consultative Group on Drugs, ; , COLLABORATORS; Alonso, PL; Bassat, Q; Binka, F; Brewer, T; Chandra, R; Culpepper, J; Dinglasan, R; Duncan, K; Duparc, S; Fukuda, M; Laxminarayan, R; MacArthur, JR; Magill, A; Marzetta, C; Milman, J; Mutabingwa, T; Nosten, F; Nwaka, S; Nyunt, M; Ohrt, C; Plowe, CV; Pottage, J; Price, R; Ringwald, P; Serazin, A; Shanks, D; Sinden, R; Tanner, M; Vial, H; Ward, SA; Wellems, TE; Wells, T; White, N; Wirth, D; Yeung, S; Yuthavong, Y; Alonso, PL; Djimde, A; Magill, A; Milman, J; Nájera, J; Plowe, CV; Wells, T; Yeung, S; Kremsner, P; Mueller, I; Newman, RD; Rabinovich, R; (2011) A research agenda for malaria eradication: drugs. PLoS medicine, 8 (1). e1000402. ISSN 1549-1277 DOI: https://doi.org/10.1371/journal.pmed.1000402

[img]
Preview
Text - Published Version
License:

Download (134kB) | Preview

Abstract

: Antimalarial drugs will be essential tools at all stages of malaria elimination along the path towards eradication, including the early control or "attack" phase to drive down transmission and the later stages of maintaining interruption of transmission, preventing reintroduction of malaria, and eliminating the last residual foci of infection. Drugs will continue to be used to treat acute malaria illness and prevent complications in vulnerable groups, but better drugs are needed for elimination-specific indications such as mass treatment, curing asymptomatic infections, curing relapsing liver stages, and preventing transmission. The ideal malaria eradication drug is a coformulated drug combination suitable for mass administration that can be administered in a single encounter at infrequent intervals and that results in radical cure of all life cycle stages of all five malaria species infecting humans. Short of this optimal goal, highly desirable drugs might have limitations such as targeting only one or two parasite species, the priorities being Plasmodium falciparum and Plasmodium vivax. The malaria research agenda for eradication should include research aimed at developing such drugs and research to develop situation-specific strategies for using both current and future drugs to interrupt malaria transmission.<br/>

Item Type: Article
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
Research Centre: Malaria Centre
PubMed ID: 21311580
Web of Science ID: 286594200017
URI: http://researchonline.lshtm.ac.uk/id/eprint/1319768

Statistics


Download activity - last 12 months
Downloads since deposit
1,240Downloads
396Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item